世界のCISインスリン市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global CIS Insulin Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1344 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、CISインスリンのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（長時間作用型アナログ、速効型アナログ、プレミックスアナログ、中間インスリン、短時間作用型インスリン、プレミックスインスリン）、用途別市場規模（I型・その他糖尿病、II型糖尿病）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・CISインスリンの市場動向 ・企業の競争状況、市場シェア ・CISインスリンの種類別市場規模（長時間作用型アナログ、速効型アナログ、プレミックスアナログ、中間インスリン、短時間作用型インスリン、プレミックスインスリン） ・CISインスリンの用途別市場規模（I型・その他糖尿病、II型糖尿病） ・CISインスリンの北米市場規模2016-2027（アメリカ、カナダ） ・CISインスリンのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・CISインスリンのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・CISインスリンの中南米市場規模2016-2027（メキシコ、ブラジル） ・CISインスリンの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Eli Lilly、Novo Nordisk、Takeda Pharmaceuticals、Sanofi Aventis、Nanjing Xinbai Pharmaceutical、Oramed Pharmaceuticals、Merck、Boehringer Ingelheim、Biocon） ・結論

Insulin is a peptide hormone produced by beta cells of the pancreatic islets, which is considered to be the main anabolic hormone of the body.
Russia is estimated to witness a significant growth over the next decade owing to the various subsidies provided by the local government.

Market Analysis and Insights: Global CIS Insulin Market
The global CIS Insulin market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global CIS Insulin market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global CIS Insulin market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global CIS Insulin market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global CIS Insulin market.

Global CIS Insulin Scope and Market Size
CIS Insulin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global CIS Insulin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Long-Acting Analog
Rapid Acting Analog
Premixed Analog
Intermediate Insulin
Short Acting Insulin
Premixed Insulin

Segment by Application
Type I and Other Diabetes
Type II Diabetes

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Eli Lilly
Novo Nordisk
Takeda Pharmaceuticals
Sanofi Aventis
Nanjing Xinbai Pharmaceutical
Oramed Pharmaceuticals
Merck
Boehringer Ingelheim
Biocon

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CIS Insulin Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Long-Acting Analog
1.2.3 Rapid Acting Analog
1.2.4 Premixed Analog
1.2.5 Intermediate Insulin
1.2.6 Short Acting Insulin
1.2.7 Premixed Insulin
1.3 Market by Application
1.3.1 Global CIS Insulin Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Type I and Other Diabetes
1.3.3 Type II Diabetes
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global CIS Insulin Market Perspective (2016-2027)
2.2 CIS Insulin Growth Trends by Regions
2.2.1 CIS Insulin Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 CIS Insulin Historic Market Share by Regions (2016-2021)
2.2.3 CIS Insulin Forecasted Market Size by Regions (2022-2027)
2.3 CIS Insulin Industry Dynamic
2.3.1 CIS Insulin Market Trends
2.3.2 CIS Insulin Market Drivers
2.3.3 CIS Insulin Market Challenges
2.3.4 CIS Insulin Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top CIS Insulin Players by Revenue
3.1.1 Global Top CIS Insulin Players by Revenue (2016-2021)
3.1.2 Global CIS Insulin Revenue Market Share by Players (2016-2021)
3.2 Global CIS Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by CIS Insulin Revenue
3.4 Global CIS Insulin Market Concentration Ratio
3.4.1 Global CIS Insulin Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CIS Insulin Revenue in 2020
3.5 CIS Insulin Key Players Head office and Area Served
3.6 Key Players CIS Insulin Product Solution and Service
3.7 Date of Enter into CIS Insulin Market
3.8 Mergers & Acquisitions, Expansion Plans

4 CIS Insulin Breakdown Data by Type
4.1 Global CIS Insulin Historic Market Size by Type (2016-2021)
4.2 Global CIS Insulin Forecasted Market Size by Type (2022-2027)

5 CIS Insulin Breakdown Data by Application
5.1 Global CIS Insulin Historic Market Size by Application (2016-2021)
5.2 Global CIS Insulin Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America CIS Insulin Market Size (2016-2027)
6.2 North America CIS Insulin Market Size by Type
6.2.1 North America CIS Insulin Market Size by Type (2016-2021)
6.2.2 North America CIS Insulin Market Size by Type (2022-2027)
6.2.3 North America CIS Insulin Market Size by Type (2016-2027)
6.3 North America CIS Insulin Market Size by Application
6.3.1 North America CIS Insulin Market Size by Application (2016-2021)
6.3.2 North America CIS Insulin Market Size by Application (2022-2027)
6.3.3 North America CIS Insulin Market Size by Application (2016-2027)
6.4 North America CIS Insulin Market Size by Country
6.4.1 North America CIS Insulin Market Size by Country (2016-2021)
6.4.2 North America CIS Insulin Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe CIS Insulin Market Size (2016-2027)
7.2 Europe CIS Insulin Market Size by Type
7.2.1 Europe CIS Insulin Market Size by Type (2016-2021)
7.2.2 Europe CIS Insulin Market Size by Type (2022-2027)
7.2.3 Europe CIS Insulin Market Size by Type (2016-2027)
7.3 Europe CIS Insulin Market Size by Application
7.3.1 Europe CIS Insulin Market Size by Application (2016-2021)
7.3.2 Europe CIS Insulin Market Size by Application (2022-2027)
7.3.3 Europe CIS Insulin Market Size by Application (2016-2027)
7.4 Europe CIS Insulin Market Size by Country
7.4.1 Europe CIS Insulin Market Size by Country (2016-2021)
7.4.2 Europe CIS Insulin Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific CIS Insulin Market Size (2016-2027)
8.2 Asia-Pacific CIS Insulin Market Size by Type
8.2.1 Asia-Pacific CIS Insulin Market Size by Type (2016-2021)
8.2.2 Asia-Pacific CIS Insulin Market Size by Type (2022-2027)
8.2.3 Asia-Pacific CIS Insulin Market Size by Type (2016-2027)
8.3 Asia-Pacific CIS Insulin Market Size by Application
8.3.1 Asia-Pacific CIS Insulin Market Size by Application (2016-2021)
8.3.2 Asia-Pacific CIS Insulin Market Size by Application (2022-2027)
8.3.3 Asia-Pacific CIS Insulin Market Size by Application (2016-2027)
8.4 Asia-Pacific CIS Insulin Market Size by Region
8.4.1 Asia-Pacific CIS Insulin Market Size by Region (2016-2021)
8.4.2 Asia-Pacific CIS Insulin Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America CIS Insulin Market Size (2016-2027)
9.2 Latin America CIS Insulin Market Size by Type
9.2.1 Latin America CIS Insulin Market Size by Type (2016-2021)
9.2.2 Latin America CIS Insulin Market Size by Type (2022-2027)
9.2.3 Latin America CIS Insulin Market Size by Type (2016-2027)
9.3 Latin America CIS Insulin Market Size by Application
9.3.1 Latin America CIS Insulin Market Size by Application (2016-2021)
9.3.2 Latin America CIS Insulin Market Size by Application (2022-2027)
9.3.3 Latin America CIS Insulin Market Size by Application (2016-2027)
9.4 Latin America CIS Insulin Market Size by Country
9.4.1 Latin America CIS Insulin Market Size by Country (2016-2021)
9.4.2 Latin America CIS Insulin Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa CIS Insulin Market Size (2016-2027)
10.2 Middle East & Africa CIS Insulin Market Size by Type
10.2.1 Middle East & Africa CIS Insulin Market Size by Type (2016-2021)
10.2.2 Middle East & Africa CIS Insulin Market Size by Type (2022-2027)
10.2.3 Middle East & Africa CIS Insulin Market Size by Type (2016-2027)
10.3 Middle East & Africa CIS Insulin Market Size by Application
10.3.1 Middle East & Africa CIS Insulin Market Size by Application (2016-2021)
10.3.2 Middle East & Africa CIS Insulin Market Size by Application (2022-2027)
10.3.3 Middle East & Africa CIS Insulin Market Size by Application (2016-2027)
10.4 Middle East & Africa CIS Insulin Market Size by Country
10.4.1 Middle East & Africa CIS Insulin Market Size by Country (2016-2021)
10.4.2 Middle East & Africa CIS Insulin Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Details
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly CIS Insulin Introduction
11.1.4 Eli Lilly Revenue in CIS Insulin Business (2016-2021)
11.1.5 Eli Lilly Recent Development
11.2 Novo Nordisk
11.2.1 Novo Nordisk Company Details
11.2.2 Novo Nordisk Business Overview
11.2.3 Novo Nordisk CIS Insulin Introduction
11.2.4 Novo Nordisk Revenue in CIS Insulin Business (2016-2021)
11.2.5 Novo Nordisk Recent Development
11.3 Takeda Pharmaceuticals
11.3.1 Takeda Pharmaceuticals Company Details
11.3.2 Takeda Pharmaceuticals Business Overview
11.3.3 Takeda Pharmaceuticals CIS Insulin Introduction
11.3.4 Takeda Pharmaceuticals Revenue in CIS Insulin Business (2016-2021)
11.3.5 Takeda Pharmaceuticals Recent Development
11.4 Sanofi Aventis
11.4.1 Sanofi Aventis Company Details
11.4.2 Sanofi Aventis Business Overview
11.4.3 Sanofi Aventis CIS Insulin Introduction
11.4.4 Sanofi Aventis Revenue in CIS Insulin Business (2016-2021)
11.4.5 Sanofi Aventis Recent Development
11.5 Nanjing Xinbai Pharmaceutical
11.5.1 Nanjing Xinbai Pharmaceutical Company Details
11.5.2 Nanjing Xinbai Pharmaceutical Business Overview
11.5.3 Nanjing Xinbai Pharmaceutical CIS Insulin Introduction
11.5.4 Nanjing Xinbai Pharmaceutical Revenue in CIS Insulin Business (2016-2021)
11.5.5 Nanjing Xinbai Pharmaceutical Recent Development
11.6 Oramed Pharmaceuticals
11.6.1 Oramed Pharmaceuticals Company Details
11.6.2 Oramed Pharmaceuticals Business Overview
11.6.3 Oramed Pharmaceuticals CIS Insulin Introduction
11.6.4 Oramed Pharmaceuticals Revenue in CIS Insulin Business (2016-2021)
11.6.5 Oramed Pharmaceuticals Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck CIS Insulin Introduction
11.7.4 Merck Revenue in CIS Insulin Business (2016-2021)
11.7.5 Merck Recent Development
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Details
11.8.2 Boehringer Ingelheim Business Overview
11.8.3 Boehringer Ingelheim CIS Insulin Introduction
11.8.4 Boehringer Ingelheim Revenue in CIS Insulin Business (2016-2021)
11.8.5 Boehringer Ingelheim Recent Development
11.9 Biocon
11.9.1 Biocon Company Details
11.9.2 Biocon Business Overview
11.9.3 Biocon CIS Insulin Introduction
11.9.4 Biocon Revenue in CIS Insulin Business (2016-2021)
11.9.5 Biocon Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global CIS Insulin Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Long-Acting Analog
Table 3. Key Players of Rapid Acting Analog
Table 4. Key Players of Premixed Analog
Table 5. Key Players of Intermediate Insulin
Table 6. Key Players of Short Acting Insulin
Table 7. Key Players of Premixed Insulin
Table 8. Global CIS Insulin Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global CIS Insulin Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global CIS Insulin Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global CIS Insulin Market Share by Regions (2016-2021)
Table 12. Global CIS Insulin Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global CIS Insulin Market Share by Regions (2022-2027)
Table 14. CIS Insulin Market Trends
Table 15. CIS Insulin Market Drivers
Table 16. CIS Insulin Market Challenges
Table 17. CIS Insulin Market Restraints
Table 18. Global CIS Insulin Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global CIS Insulin Market Share by Players (2016-2021)
Table 20. Global Top CIS Insulin Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CIS Insulin as of 2020)
Table 21. Ranking of Global Top CIS Insulin Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by CIS Insulin Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players CIS Insulin Product Solution and Service
Table 25. Date of Enter into CIS Insulin Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global CIS Insulin Market Size by Type (2016-2021) (US$ Million)
Table 28. Global CIS Insulin Revenue Market Share by Type (2016-2021)
Table 29. Global CIS Insulin Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global CIS Insulin Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global CIS Insulin Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global CIS Insulin Revenue Market Share by Application (2016-2021)
Table 33. Global CIS Insulin Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global CIS Insulin Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America CIS Insulin Market Size by Type (2016-2021) (US$ Million)
Table 36. North America CIS Insulin Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America CIS Insulin Market Size by Application (2016-2021) (US$ Million)
Table 38. North America CIS Insulin Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America CIS Insulin Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America CIS Insulin Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe CIS Insulin Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe CIS Insulin Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe CIS Insulin Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe CIS Insulin Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe CIS Insulin Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe CIS Insulin Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific CIS Insulin Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific CIS Insulin Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific CIS Insulin Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific CIS Insulin Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific CIS Insulin Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific CIS Insulin Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America CIS Insulin Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America CIS Insulin Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America CIS Insulin Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America CIS Insulin Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America CIS Insulin Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America CIS Insulin Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa CIS Insulin Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa CIS Insulin Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa CIS Insulin Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa CIS Insulin Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa CIS Insulin Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa CIS Insulin Market Size by Country (2022-2027) & (US$ Million)
Table 65. Eli Lilly Company Details
Table 66. Eli Lilly Business Overview
Table 67. Eli Lilly CIS Insulin Product
Table 68. Eli Lilly Revenue in CIS Insulin Business (2016-2021) & (US$ Million)
Table 69. Eli Lilly Recent Development
Table 70. Novo Nordisk Company Details
Table 71. Novo Nordisk Business Overview
Table 72. Novo Nordisk CIS Insulin Product
Table 73. Novo Nordisk Revenue in CIS Insulin Business (2016-2021) & (US$ Million)
Table 74. Novo Nordisk Recent Development
Table 75. Takeda Pharmaceuticals Company Details
Table 76. Takeda Pharmaceuticals Business Overview
Table 77. Takeda Pharmaceuticals CIS Insulin Product
Table 78. Takeda Pharmaceuticals Revenue in CIS Insulin Business (2016-2021) & (US$ Million)
Table 79. Takeda Pharmaceuticals Recent Development
Table 80. Sanofi Aventis Company Details
Table 81. Sanofi Aventis Business Overview
Table 82. Sanofi Aventis CIS Insulin Product
Table 83. Sanofi Aventis Revenue in CIS Insulin Business (2016-2021) & (US$ Million)
Table 84. Sanofi Aventis Recent Development
Table 85. Nanjing Xinbai Pharmaceutical Company Details
Table 86. Nanjing Xinbai Pharmaceutical Business Overview
Table 87. Nanjing Xinbai Pharmaceutical CIS Insulin Product
Table 88. Nanjing Xinbai Pharmaceutical Revenue in CIS Insulin Business (2016-2021) & (US$ Million)
Table 89. Nanjing Xinbai Pharmaceutical Recent Development
Table 90. Oramed Pharmaceuticals Company Details
Table 91. Oramed Pharmaceuticals Business Overview
Table 92. Oramed Pharmaceuticals CIS Insulin Product
Table 93. Oramed Pharmaceuticals Revenue in CIS Insulin Business (2016-2021) & (US$ Million)
Table 94. Oramed Pharmaceuticals Recent Development
Table 95. Merck Company Details
Table 96. Merck Business Overview
Table 97. Merck CIS Insulin Product
Table 98. Merck Revenue in CIS Insulin Business (2016-2021) & (US$ Million)
Table 99. Merck Recent Development
Table 100. Boehringer Ingelheim Company Details
Table 101. Boehringer Ingelheim Business Overview
Table 102. Boehringer Ingelheim Revenue in CIS Insulin Business (2016-2021) & (US$ Million)
Table 103. Boehringer Ingelheim Recent Development
Table 104. Biocon Company Details
Table 105. Biocon Business Overview
Table 106. Biocon CIS Insulin Product
Table 107. Biocon Revenue in CIS Insulin Business (2016-2021) & (US$ Million)
Table 108. Biocon Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CIS Insulin Market Share by Type: 2020 VS 2027
Figure 2. Long-Acting Analog Features
Figure 3. Rapid Acting Analog Features
Figure 4. Premixed Analog Features
Figure 5. Intermediate Insulin Features
Figure 6. Short Acting Insulin Features
Figure 7. Premixed Insulin Features
Figure 8. Global CIS Insulin Market Share by Application: 2020 VS 2027
Figure 9. Type I and Other Diabetes Case Studies
Figure 10. Type II Diabetes Case Studies
Figure 11. CIS Insulin Report Years Considered
Figure 12. Global CIS Insulin Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global CIS Insulin Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global CIS Insulin Market Share by Regions: 2020 VS 2027
Figure 15. Global CIS Insulin Market Share by Regions (2022-2027)
Figure 16. Global CIS Insulin Market Share by Players in 2020
Figure 17. Global Top CIS Insulin Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CIS Insulin as of 2020
Figure 18. The Top 10 and 5 Players Market Share by CIS Insulin Revenue in 2020
Figure 19. Global CIS Insulin Revenue Market Share by Type (2016-2021)
Figure 20. Global CIS Insulin Revenue Market Share by Type (2022-2027)
Figure 21. North America CIS Insulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America CIS Insulin Market Share by Type (2016-2027)
Figure 23. North America CIS Insulin Market Share by Application (2016-2027)
Figure 24. North America CIS Insulin Market Share by Country (2016-2027)
Figure 25. United States CIS Insulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada CIS Insulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe CIS Insulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe CIS Insulin Market Share by Type (2016-2027)
Figure 29. Europe CIS Insulin Market Share by Application (2016-2027)
Figure 30. Europe CIS Insulin Market Share by Country (2016-2027)
Figure 31. Germany CIS Insulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France CIS Insulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. CIS Insulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy CIS Insulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia CIS Insulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic CIS Insulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific CIS Insulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific CIS Insulin Market Share by Type (2016-2027)
Figure 39. Asia-Pacific CIS Insulin Market Share by Application (2016-2027)
Figure 40. Asia-Pacific CIS Insulin Market Share by Region (2016-2027)
Figure 41. China CIS Insulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan CIS Insulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea CIS Insulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia CIS Insulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India CIS Insulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia CIS Insulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America CIS Insulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America CIS Insulin Market Share by Type (2016-2027)
Figure 49. Latin America CIS Insulin Market Share by Application (2016-2027)
Figure 50. Latin America CIS Insulin Market Share by Country (2016-2027)
Figure 51. Mexico CIS Insulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil CIS Insulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa CIS Insulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa CIS Insulin Market Share by Type (2016-2027)
Figure 55. Middle East & Africa CIS Insulin Market Share by Application (2016-2027)
Figure 56. Middle East & Africa CIS Insulin Market Share by Country (2016-2027)
Figure 57. Turkey CIS Insulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia CIS Insulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE CIS Insulin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Eli Lilly Revenue Growth Rate in CIS Insulin Business (2016-2021)
Figure 61. Novo Nordisk Revenue Growth Rate in CIS Insulin Business (2016-2021)
Figure 62. Takeda Pharmaceuticals Revenue Growth Rate in CIS Insulin Business (2016-2021)
Figure 63. Sanofi Aventis Revenue Growth Rate in CIS Insulin Business (2016-2021)
Figure 64. Nanjing Xinbai Pharmaceutical Revenue Growth Rate in CIS Insulin Business (2016-2021)
Figure 65. Oramed Pharmaceuticals Revenue Growth Rate in CIS Insulin Business (2016-2021)
Figure 66. Merck Revenue Growth Rate in CIS Insulin Business (2016-2021)
Figure 67. Boehringer Ingelheim Revenue Growth Rate in CIS Insulin Business (2016-2021)
Figure 68. Biocon Revenue Growth Rate in CIS Insulin Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---